Back to Results
First PageMeta Content
Pharmacology / Temozolomide / Glioblastoma multiforme / Tumor Treating Fields / Oligodendroglioma / Glioma / Brain tumor / Medicine / Oncology


Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success Data presented today as a late
Add to Reading List

Document Date: 2014-11-20 09:23:21


Open Document

File Size: 69,88 KB

Share Result on Facebook
UPDATE